HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$0.97
Day range
$0.94 - $0.97
Year range
$0.81 - $5.95
Market cap
12.35M USD
Avg Volume
1.86M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 861.18K | -26.35% |
Operating expense | 945.16K | -17.23% |
Net income | -4.02M | -83.14% |
Net profit margin | -466.28 | -148.64% |
Earnings per share | -0.29 | -16.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.46M | 34.12% |
Total assets | 14.77M | 26.49% |
Total liabilities | 4.28M | 116.88% |
Total equity | 10.49M | — |
Shares outstanding | 12.94M | — |
Price to book | 1.04 | — |
Return on assets | -67.08% | — |
Return on capital | -85.28% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.02M | -83.14% |
Cash from operations | -1.88M | 47.35% |
Cash from investing | — | — |
Cash from financing | 100.00 | -99.78% |
Net change in cash | -1.88M | 46.69% |
Free cash flow | -1.88M | 33.30% |
About
Founded
1992
Headquarters
Website
Employees
5
